These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1134 related items for PubMed ID: 8831181

  • 1. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S, de Divitiis M, Bertocchi F, Carotenuto A, Cudemo G, Petitto M, Napodano M, de Divitiis O.
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [Abstract] [Full Text] [Related]

  • 2. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M, Tracz W, Kubler G, Negrusz-Kawecka M, Hlawaty M, Olszowska M, Salamon P.
    Przegl Lek; 1997 Jul; 54(5):324-8. PubMed ID: 9380807
    [Abstract] [Full Text] [Related]

  • 3. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B, Paoletti G, Pelizza L, Bertulla A, Motolese M.
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K, Bestehorn HP, Roskamm H.
    J Cardiovasc Pharmacol; 1990 Apr; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy].
    Mazzotta G, Falcidieno M, Ravera E, Vecchio C.
    G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025
    [Abstract] [Full Text] [Related]

  • 7. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, Skibińska E, Szymczak K, Swiatek J, Winter M.
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [Abstract] [Full Text] [Related]

  • 8. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L, Hjemdahl P, Held C, Björkander I, Eriksson SV, Brodin U, Rehnqvist N.
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
    Di Pasquale G, Lusa AM, Manini GL, Dominici P, Coluccini M, Bassein L, Pinelli G.
    G Ital Cardiol; 1984 Aug; 14(8):618-20. PubMed ID: 6500225
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M.
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G, Negrini M, Mazzocchi F, Prina L, Pollavini P, De Ponti C.
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
    Savonitto S, Ardissiono D, Egstrup K, Rasmussen K, Bae EA, Omland T, Schjelderup-Mathiesen PM, Marraccini P, Wahlqvist I, Merlini PA, Rehnqvist N.
    J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 20. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Nov; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.